These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10448423)

  • 1. Activation of neurotransplants in humans.
    Blüml S; Kopyov O; Jacques S; Ross BD
    Exp Neurol; 1999 Jul; 158(1):121-5. PubMed ID: 10448423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
    Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
    Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotransplantation in Parkinson disease: experimental and clinical results of functional reconstruction of the dopaminergic system].
    Nikkhah G; Brandis A
    Zentralbl Neurochir; 1995; 56(4):153-60. PubMed ID: 8571693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease].
    Yang H; Zhang K; Cai W
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease.
    Diederich NJ; Goetz CG
    Brain Cogn; 2000 Mar; 42(2):294-306. PubMed ID: 10744925
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intracerebral grafts in Parkinson disease. Current experiences and perspectives].
    Levivier M
    Bull Mem Acad R Med Belg; 1999; 154(1):99-106; discussion 106-9. PubMed ID: 10535160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simultaneous micro-transplantation of fetal mesencephalic cells to the striate and substantia nigra pars reticulata in hemi-parkinsonian rats. A study of behavior].
    Blanco L; Pavón N; Macías R; Castillo L; Díaz C; García A; Alvarez P
    Rev Neurol; 2000 Jun 16-30; 30(12):1122-7. PubMed ID: 10935235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral fetal mesencephalic grafting in two patients with Parkinson's disease: short-term result after transplantation.
    Chung CK; Kim HJ; Jeon BS; Kim YS; Lee SB; Han DH
    No Shinkei Geka; 1996 Nov; 24(11):987-93. PubMed ID: 8934466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model.
    Goren B; Kahveci N; Eyigor O; Alkan T; Korfali E; Ozluk K
    Surg Neurol; 2005; 64 Suppl 2():S33-41. PubMed ID: 16256839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep brain stimulation in Parkinson's disease following fetal nigral transplantation.
    Herzog J; Pogarell O; Pinsker MO; Kupsch A; Oertel WH; Lindvall O; Deuschl G; Volkmann J
    Mov Disord; 2008 Jul; 23(9):1293-6. PubMed ID: 18536037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of intrastriatal neurotransplantation for Huntington's disease patients.
    Kopyov OV; Jacques S; Lieberman A; Duma CM; Eagle KS
    Exp Neurol; 1998 Jan; 149(1):97-108. PubMed ID: 9454619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
    Kordower JH; Freeman TB; Olanow CW
    Mov Disord; 1998; 13 Suppl 1():88-95. PubMed ID: 9613724
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
    Piccini P; Brooks DJ; Björklund A; Gunn RN; Grasby PM; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
    Nat Neurosci; 1999 Dec; 2(12):1137-40. PubMed ID: 10570493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-stereotactical approach for neural grafting in basal ganglia disorders.
    Palfi S; Nguyen JP; Brugieres P; Le Guerinel C; Hantraye P; Remy P; Rostaing S; Defer GL; Cesaro P; Keravel Y; Peschanski M
    Exp Neurol; 1998 Apr; 150(2):272-81. PubMed ID: 9527897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
    Kirik D; Björklund A
    Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
    [No Abstract]   [Full Text] [Related]  

  • 17. A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting.
    Baker KA; Purdy MB; Sadi D; Mukhida K; Mendez I
    Cell Transplant; 2002; 11(3):185-93. PubMed ID: 12075984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of Parkinson's disease.
    Krauss JK; Jankovic J
    Am Fam Physician; 1996 Oct; 54(5):1621-9. PubMed ID: 8857784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease.
    Cerasa A; Hagberg GE; Peppe A; Bianciardi M; Gioia MC; Costa A; Castriota-Scanderbeg A; Caltagirone C; Sabatini U
    Brain Res Bull; 2006 Dec; 71(1-3):259-69. PubMed ID: 17113955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY; Li YX; Zee CS
    Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.